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Thyroid hormones (THs) are key regulators in the development of the vertebrate brain. Therefore, TH
access to the developing brain needs to be strictly regulated. The brain barriers separate the central ner-
vous system from the rest of the body and impose specific transport mechanisms on the exchange of
molecules between the general circulation and the nervous system. As such they form ideal structures
for regulating TH exchange between the blood and the brain. To investigate the mechanism by which
the developing brain regulates TH availability, we investigated the ontogenetic expression profiles of
TH transporters, deiodinases and the TH distributor protein transthyretin (TTR) at the brain barriers dur-
ing embryonic and early postnatal development using the chicken as a model. In situ hybridisation
revealed expression of the TH transporters monocarboxylate transporter 8 (MCT8) and 10 (MCT10),
organic anion transporting polypeptide 1C1 (OATP1C1) and L-type amino acid transporter 1 (LAT1) and
the inactivating type 3 deiodinase (D3) in the choroid plexus which forms the blood–cerebrospinal fluid
barrier. This was confirmed by quantitative PCR which additionally indicated strongly increasing expres-
sion of TTR as well as detectable expression of the activating type 2 deiodinase (D2) and the (in)activating
type 1 deiodinase (D1). In the brain capillaries forming the blood–brain barrier in situ hybridisation
showed exclusive expression of LAT1 and D2. The combined presence of LAT1 and D2 in brain capillaries
suggests that the blood–brain barrier forms the main route for receptor-active T3 uptake into the embry-
onic chicken brain. Expression of multiple transporters, deiodinases and TTR in the choroid plexus
indicates that the blood–cerebrospinal fluid barrier is also important in regulating early TH availability.
The impact of these barrier systems can be deduced from the clear difference in T3 and T4 levels as well as
the T3/T4 ratio between the developing brain and the general circulation. We conclude that the tight
regulation of TH exchange at the brain barriers from early embryonic stages is one of the factors needed
to allow the brain to develop within a relative microenvironment.
 2015 Published by Elsevier Inc.1. Introduction This is especially true for the brain where TH deficiency is linkedThyroid hormones (THs) play an important role in the
functioning and development of many tissues and organ systems.to several neurodevelopmental impairments as well as depression
and memory and concentration problems in adults (Bernal et al.,
2003; Feldman et al., 2013). During neurodevelopment THs are
key regulators in cell proliferation, differentiation and migration,
neurite outgrowth, synaptogenesis and myelination (Williams,
2008). Control of TH access to the brain is therefore a prerequisite
for normal brain development and functioning.
THs mainly act through binding of 3,5,30-triiodothyronine (T3)
to TH receptors which control gene expression in the nucleus
(Harvey and Williams, 2002). TH action in the brain thus depends
on the intracellular availability of T3 and its receptors. In the
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thyretin (TTR). These TH distributor proteins prevent the lipophilic
THs from partitioning into the cell membranes and could be
involved in TH uptake into the brain (Richardson, 2007). The pre-
dominant TH in circulation is thyroxine (T4) that can be deiodi-
nated to the receptor-active T3 by the type 2 deiodinase (D2)
which is present in many cells. T3 in turn can be inactivated to
3,30-T2 by the intracellular type 3 deiodinase (D3) (Gereben et al.,
2008). To enter the cells THs require specific transporter proteins
to cross the plasma membrane (Visser et al., 2008). TH transporter
proteins include those belonging to the organic anion transporter
family (OATPs), L-type amino acid transporters (LATs) and mono-
carboxylate transporters (MCTs), and have been found in the devel-
oping and adult brain of different vertebrates including mammals,
birds, amphibians and fish (Arjona et al., 2011; Chan et al., 2011;
Connors et al., 2010; Muzzio et al., 2014; Van Herck et al., 2013).
Local TH action results from the combined interaction of TH
transporters, deiodinases and receptors which are expressed in a
cell-specific pattern. In the brain an additional level of regulation
exists at the brain barriers that separate the central nervous
system from the rest of the body (Ek et al., 2012; Risau, 1994).
The blood vessels (capillaries) in the brain form the blood–brain
barrier, and the choroid plexus in the ventricles forms the blood–
cerebrospinal fluid barrier (blood–CSF barrier). The cells of these
barriers are linked by tight junctions (Liu et al., 2012; Møllgård
and Saunders, 1975), inhibiting intercellular diffusion and impos-
ing transmembrane transport for entrance into the brain. At the
blood–brain barrier the tight junctions are situated at the level of
the endothelial cells of the blood vessels. In contrast, the blood
vessels within the choroid plexus are ‘‘leaky’’ while the outer
epithelial cells of the choroid plexus contain the tight junctions
and form the blood–CSF barrier. In this way these barriers are able
to control the movement of compounds, such as hormones and
nutrients, between the general circulation and the brain (Abbott
et al., 2010; Saunders et al., 2013). Expression of TH transporters
and deiodinases at the brain barriers can therefore strictly control
the amount of (active) TH reaching the brain.
Some controversy remains on the exact timing of the onset of
brain barrier function during development (Ek et al., 2012).
While tight junctions are found in the blood vessels from the
moment they start to invade the brain (Bauer et al., 1993;
Møllgård and Saunders, 1986), decreased permeability appears to
be a gradual process whereby macromolecules are excluded from
passing the embryonic blood–brain barrier already at very early
stages, but smaller molecules may pass more freely until a more
dense network of endothelial junctions appears (Engelhardt,
2003; Stewart and Hayakawa, 1987). In the chicken embryo, the
animal model used in this paper, tight junctions have been
visualised in the endothelial cells of the blood–brain barrier at
day 9 of the 21 day embryonic development (Nico et al., 1997).
Injection experiments indicated a decreasing permeability of the
brain blood vessels for Evan’s blue and horseradish peroxidase
from day 13 of development onwards (Ribatti et al., 1993; Wakai
and Hirokawa, 1978).
The ontogenetic timing of the thyroid axis maturation and brain
development in chickens largely correlates with the timing found
in developing humans (Van Herck et al., 2013). In both species
the functional maturation of the embryonic thyroid gland occurs
around mid-embryonic development and also the major part of
brain development occurs prenatally, in contrast to the situation
in rodents (Howdeshell, 2002; Thommes, 1987). This, in combina-
tion with the fact that the chicken embryo can be easily reached
through the egg and the possibility to synchronise the embryonic
development of many animals in an incubator, makes it an
appropriate and efficient model to investigate TH-regulated neu-
rodevelopment, and development of the functional brain barriers.In this paper we investigated the expression pattern of TH
transporters, deiodinases and TTR at the developing brain bar-
riers. Their expression was studied from day 8 of embryonic
development, before the onset of embryonic thyroid gland
functioning, until 11 days post-hatch, with the focus just prior
to hatching as this is a period in which the brain undergoes rapid
changes in TH metabolism (Reyns et al., 2003; Van der Geyten
et al., 2002).2. Materials and methods
2.1. Animal treatment and tissue sampling
Fertilised Ross (broiler) eggs were obtained from a commercial
hatchery (Belgabroed, Merksplas Belgium), and incubated in a
forced draft incubator at 37.5 C and 50% relative humidity and
automatically turned at a 45 angle every hour. The day on which
incubation was started was called day 0 (E0). On days E8, E10, E11,
E14, E17, E18, E19 and E20 some eggs were opened and embryonic
tissues were sampled. At E20 the chicks hatch and make the tran-
sition to C0. Additional samples were collected on post-hatch
stages C1 and C11.
Blood samples were taken by cardiac puncture (E14–E20) or
carotid artery bleeding (post-hatch) in heparinised collection
tubes. After centrifugation, plasma was stored at 20 C until
analysis. At each sampling stage the choroid plexus was collected
from the lateral ventricles in the telencephalon and the remaining
brain was divided into 5 parts: telencephalon (forebrain), dience-
phalon, mesencephalon (optic lobes) and rhombencephalon. The
rhombencephalon was subdivided into cerebellum and brain stem.
All tissue samples were snap frozen in liquid nitrogen and stored at
80 C until analysis. Whole brain samples were collected for
histological analysis. These samples were fixed overnight in 4%
paraformaldehyde in phosphate buffered saline (PBS, pH 7.4,
4 C) after which they were cryoprotected overnight in 20% sucrose
in PBS (pH 7.4, 4 C) and finally embedded in Tissue-Tek O.C.T.
compound (Sakura finetek, Alphen aan den Rijn, The
Netherlands). Samples were then frozen on a liquid nitrogen
cooled metal stub and stored at 80 C until cryosectioning. All
the experimental protocols on animals were conducted in
accordance with the European Communities Council Directive
(2010/63/EU) and were approved by the Ethical Committee for
animal experiments of the KU Leuven.2.2. In situ hybridisation (ISH)
ISH procedures were performed using digoxigenin-UTP-labelled
antisense riboprobes as previously described (Geysens et al., 2012),
based on the protocol Hidalgo-Sanchez et al. (2005). Sense probes
were used as negative controls for all genes and at different stages.
Information on the specific probes is summarised in Table 1.2.3. Reverse transcription quantitative PCR (qPCR)
RNA isolation, cDNA production and qPCR procedures were
performed as previously described (Van Herck et al., 2012).
Additional primers were designed using Primer3plus
(Untergasser et al., 2012), and information on all primer pairs is
summarised in Table 1. Relative expression values were calculated
with the StepOne Software (Life Technologies). The expression data
were normalised using the qBasePLUS Software (Biogazelle,
Zwijnaarde, Belgium). Beta actin, glyceraldehyde-3-phosphate
dehydrogenase (GAPDH), Cyclophillin A and Ubiquitin mRNAs
were used for normalisation.
Table 1
List of primers and probes used for qPCR and ISH experiments.
Protein Gene name mRNA acc nr ISH probe length (location in mRNA) Amplicon qPCR primers 50 ? 30
D1 DIO1 NM_001097614.1 / 84 Fwd: GAA CCC AAA GTT CAG CTA CGA AA
Rev: CTC CAC TTC ACC TTC AGC ACA A
D2 DIO2 NM_204114.3 911 (1021–1931) 142 Fwd: TGT TTC TGA GCC GCT CCA A
Rev: ACA CTG GAG TTC GGA GCT TCT C
D3 DIO3 NM_001122648.1 819 (264–1242) 100 Fwd: CAG GAG GAG AAG GTG ATG TAC CA
Rev: TCT GGA GCC GGG TTT TGT ACT
MCT8 SLC16A2 XM_426274.4 894 (2089–2982) 95 Fwd: CAA CTC CTT CGG GAT CAT CTA CA
Rev: AGC CAA CCC ATG CTG TTT TAA
MCT10 SLC16A10 XM_419783.4 881 (317–1197) 137 Fwd: ACC CCT TGT TTC CAA CAC C
Rev: GTG CAG CAG GAA TGC CAA AA
OATP1C1 SLCO1C1 NM_001039097.1 943 (912–1854) 97 Fwd: CAT GGG ACG ATA TCA GTA TGA AAG A
Rev: CGA GAG TGG AGT TTG GCT TTT CT
LAT1 SLC7A5 NM_001030579.1 801 (141–941) 164 Fwd: CCT CCT CGC AGT ACA TCG TC
Rev: AAC ACG GGT AGC AGC TTT CA
TTR TTR NM_001281498.1 / 85 Fwd: ATT TCT CTC CGA AGC TGC AC
NM_205335.3 Rev: GAC TGC ATC CAG CAC TTT CA
Beta actin ACTB NM_205518.1 / 120 Fwd: ATG GCT CCG GTA TGT GCA A
Rev: TGT CTT TCT GGC CCA TAC CAA
GAPDH GAPDH NM_204305.1 / 97 Fwd: GAA GCT TAC TGG AAT GGC TTT CC
Rev: GAT ATC ATC ATA CTT GGC TGG TTT CTC
Cyclophilin A PPIA NM_001166326.1 / 77 Fwd: GGC TAC AAG GGC TCC TGC TT
Rev: CCG TTG TGG CGC GTA AA
Ubiquitin UBC M11100.1 / 68 Fwd: GCG CCT CAG GGG TGG CTA TT
Rev: CAC ACA ATG TGC TGT GCA TCT TGC
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In vitro deiodination activities were determined as previously
described (Darras et al., 1992, 1996). Homogenates were prepared
from tissue pools of 6 choroid plexi each. Tests were performed for
5 different stages: E14, E18, E20, C1 and C11, and 2 tissue pools
were used per stage. Each sample was homogenised in 1 ml of buf-
fer solution (2 mM EDTA, 100 mM phosphate and 1 mM DTT, pH
7.2). To determine the D1 activity, the incubation mixture (total
volume 200 ll) contained 100 ll undiluted homogenate and a final
concentration of 1 lM rT3 containing 50,000 cpm of radiolabelled
[125I]-rT3. The tubes were incubated at 37 C for 60 min. D2 activity
was assayed in a similar way by incubating 100 ll homogenate
with 1 nM T4 + 50,000 cpm [125I]-T4 at 37 C for 240 min in the
presence of 0.1 mM 6n-propylthiouracil (PTU) to block possible
D1 interference. In the D3 activity test, the incubationmixture con-
tained 100 ll of 1/5 diluted homogenate and 1 nM
T3 + 150,000 cpm [125I]-T3 as well as 1 lM rT3 and 0.1 mM PTU to
block possible D1 interference. The mixture was incubated for
120 min at 37 C. Activities were calculated as amount of hormone
deiodinated per mg protein and per minute.2.5. Determination of T4 and T3 levels
T4 and T3 levels were measured in brain tissues from E14, E18
and C11 birds. At E14 the samples consisted of pools of 3 animals
(n = 6 pooled samples), at the other stages the TH levels were
determined from individual animals (n = 6). Extraction and
radioimmunoassay (RIA) were performed as previously described
(Reyns et al., 2002, 2005). Hormone levels are expressed as
picomol per gram tissue. T4 and T3 levels in plasma samples were
measured by the same RIA systemwithout extraction (Darras et al.,
1996), using a standard in hormone-free human serum
(Byk-Sangtec Diagnostica, Germany) and results are expressed as
picomol per ml plasma.2.6. Statistics
Statistical analysis was performed using the general linear mod-
els procedure in the SAS software (SAS Institute Inc, NC, USA). Datafrom the qPCR experiments were analysed by one-way analysis of
variance (ANOVA) followed by Scheffé’s post hoc test to identify
statistical significant changes for each gene over time.
Data from the TH determinations were first analysed by two-
way ANOVA to identify significant influences of tissue (forebrain,
diencephalon, optic lobes, cerebellum, brain stem, and for T3/T4
ratio also plasma) and stage as well as tissue*stage interactions.
This was followed by one-way ANOVA with Scheffé’s post hoc test
to identify significant differences in TH levels within each tissue
over time (E14, E18 and C11) and for differences between brain
regions at a given developmental stage.
Significant changes (p < 0.05) are mentioned in the text, the full
results of the statistical analyses are provided as Supplementary
Data: Table S1.3. Results
3.1. mRNA distribution pattern of TH transporters at the brain barriers
during development
In situ hybridisation demonstrated that throughout develop-
ment there was a clear difference in the mRNA expression pattern
of the TH transporters between the two brain barriers (overview in
Table 2). mRNA of all studied transporters was found in the choroid
plexus, but only LAT1 could be visualised in the blood vessels of the
blood–brain barrier (Table 2). LAT1 expression in the blood vessels
was apparent from the earliest time point tested (E8), but
decreased around hatching and became undetectable post-hatch
(Fig. 1M–P). OATP1C1 and MCT8 were the TH transporters most
abundantly expressed in the choroid plexus during the investi-
gated period (Fig. 1A–D and I–L). In addition to the expression in
the choroid plexus, MCT8 and OATP1C1 mRNA was also present
in the ependymal cells lining the ventricle wall, most notably in
the lateral ventricles around E14 (Fig. 1B and J). MCT10 expression
was visible only at E8 in the choroid plexus and at no later stages
(Table 2). In general, expression of the TH transporters decreased at
the later (post-hatch) stages and expression was of the same mag-
nitude in the choroid plexus of the lateral ventricles and the 4th
ventricle (Table 2). The exception was OATP1C1 whose mRNA
expression was high in the choroid plexus of the lateral ventricles
Table 2
Overview of the signal intensities from all stages analysed by in situ hybridisation.
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choroid plexus of the 4th ventricle at that stage (Table 2). TH
transporter expression was also investigated at the level of the
tanycytes lining the 3rd ventricle in the hypothalamic region,
showing predominant expression of MCT8 in both pre- and post-
hatch birds (Supplementary Fig. S1).
3.2. mRNA distribution pattern of deiodinases at the brain barriers
during development
The ISH study showed contrasting expression patterns for the
D2 and D3 deiodinases at the brain barriers. mRNA of the activating
D2 was visualised primarily in the blood vessels, whereas mRNA of
its inactivating counterpart, D3, was expressed exclusively at the
blood–CSF barrier (Fig. 2, Table 2). D2 expression in the blood ves-
sels was evident already at E8 (Fig. 2A) and increased at E14, after
which it remained high until hatching (Table 2, Fig. 2A–D). D2
expression in the choroid plexus was only detectable at hatching.
D3 expression in the choroid plexus was high throughout embry-
onic development, with the highest expression at E14–E17
(Table 2, Fig. 2E–H). Similar to the results of the TH transporters,
staining intensities of both deiodinases decreased at the later time
points studied (Table 2). At the level of the tanycytes we found
expression of D2 (Supplementary Fig. S1) but not D3 mRNA.3.3. TH transporter expression dynamics in the choroid plexus during
development
To investigate the quantitative changes over time, we comple-
mented the ISH studies with qPCR analysis of choroid plexus
samples from the lateral ventricles (Fig. 3). The changes in TH
transporter expression correlated well with the ISH observations.
Statistical analysis showed that mRNA expression of the TH trans-
porters varied significantly over time (MCT8: F8 = 5.49 p < 0.0001;
MCT10: F8 = 4.01 p = 0.0012; OATP1C1: F8 = 40.39 p < 0.0001;
LAT1: F8 = 13.59 p < 0.0001). MCT8, LAT1 and OATP1C1 increased
significantly from E8 until E14 (Fig. 3A, Supplementary
Table S1). At E14, MCT8 and LAT1 reached their peak expression
in the choroid plexus, after which LAT1 expression significantly
decreased (p < 0.001). MCT8 expression decreased after E14
(Fig. 3A), although the difference only became significant at C11
(Supplementary Table S1). OATP1C1 expression continued to
increase after E14 and reached peak expression around hatching,
after which expression remained high and not significantly differ-
ent from hatching values (Fig. 3A, Supplementary Table S1).
MCT10 expression was variable, with a significant increase
from E11 to E14 and a significant decrease from E14 to the later
embryonic and post-hatch stages (Fig. 3A, Supplementary
Table S1).
Fig. 2. Visualisation of deiodinase mRNA expression at the blood–brain barrier and blood–CSF barrier during embryonic and early post-hatch development (ISH). The pictures
show a representative area of the choroid plexus (CP) in the lateral ventricle (LV), the ventricle wall and a part of the forebrain (telencephalon) with blood vessels (BV) for 4 of
the developmental stages studied (E8, E14, E18 and C1). Genes are sorted in rows D2 (A–D) and D3 (E–H). The columns hold identical developmental stages. Positive areas
show blue staining and examples are indicated by arrowheads, the small panels (I and J) show negative controls (sense probe) at E18. Scale bars represent 100 lm.
Fig. 1. Visualisation of TH transporter mRNA expression at the blood–brain barrier and blood–CSF barrier during embryonic and early post-hatch development (ISH). The
pictures show a representative area of the choroid plexus (CP) in the lateral ventricle (LV), the ventricle wall and a part of the forebrain (telencephalon) with blood vessels
(BV) for 4 of the developmental stages studied (E8, E14, E18 and C1). Genes are sorted in rows: MCT8 (A–D), MCT10 (E–H), OATP1C1 (I–L) and LAT1 (M–P), the columns hold
identical developmental stages. Positive areas show blue staining and examples are indicated by arrowheads, the small panels (Q–T) show negative controls (sense probe) at
E18. Scale bars represent 100 lm.
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during development
Analysis of deiodinase mRNA expression revealed significant
changes over time (Fig. 3B) (D2: F8 = 14.74 p < 0.0001; D3:
F8 = 5.25 p < 0.0001; D1: F8 = 11.55 p < 0.0001). D2 expression sig-
nificantly increased over time with peak expression around hatch-
ing. D3, however, showed largely the opposite pattern with a highinitial expression at E8 and E11 that decreased towards E17, fol-
lowed by a significant increase towards peak levels at C1 (Fig. 3B,
Supplementary Table S1). Our deiodinase activity tests confirmed
the presence of both D2 and D3 activity in the developing choroid
plexus. Between E14 and C11 we measured an average D2 activity
of 3.9 fmol T4 deiodinated/mg protein/min and an average D3
activity of 37.5 fmol T3 deiodinated/mg protein/min. Because the
D2 test showed increased T4 deiodination in the presence of
Fig. 3. Relative quantification of TH transporter, deiodinase and TTR mRNA
expression in the choroid plexus of the developing chicken brain. Panel A. TH
transporters; B. Deiodinases; C. TTR. The relative mRNA quantity is expressed as
mean ± SEM (n = 6 for each data point), data are transformed so that the average
value of the starting point (E8) corresponds to the observed expression in the ISH
experiments (Table 2), whereby we set a clear positive signal (+) to 1, a low signal
(+/) to 0.5 and no signal () to 0.2. The starting positions of D1 and TTR (no ISH
data) were estimated based on the comparison of the E8 CT values of all the
different genes. An overview of the statistics is provided as supplementary data
(Supplementary Table S1). H = hatching (E20/C0).
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mRNA expression and enzyme activity in the choroid plexus sam-
ples. D1 mRNA expression significantly increased over time with
the highest expression at the moment of hatching (Fig. 3B,
Supplementary Table S1). The in vitro enzyme tests also showed
detectable levels of D1 activity, averaging 0.48 pmol rT3 deiodi-
nated/mg protein/min. The D1 mRNA levels were however too
low to be detected by the used ISH method.3.5. TTR expression dynamics in the choroid plexus during
development
qPCR analysis of TTR expression showed rapidly changing
expression in the choroid plexus (F8 = 51.73 p < 0.0001) (Fig. 3C).
TTR expression was present in the E8 samples and increased con-
tinuously up to hatch-C1 after which expression decreased slightly
but significantly towards C11 (Fig. 3C, Supplementary Table S1).3.6. Brain and serum T3 and T4 concentrations
Because local expression of TH transporters and deiodinases can
make a tissue relatively independent of circulating levels of THs,
we measured TH levels in the brain and compared these data to
TH levels in the general circulation (Fig. 4). In general, T3 levels
were relatively high in embryonic brain compared to T3 levels in
circulation in contrast to brain T4 levels which were relatively
low. The resulting T3/T4 ratio was therefore significantly higher
in most brain regions as compared to plasma (Fig. 4E,
Supplementary Table S1). TH levels were also significantly differ-
ent between the brain regions. At E14 and E18 T3 levels were
significantly higher in the forebrain and cerebellum as compared
to the other brain regions and this remained the case for cerebel-
lum at C11 (Fig. 4C, Supplementary Table S1). The relative changes
in T3 and T4 levels over time were also different in the brain and in
the circulation. Where T3 levels increased significantly in all brain
regions from E14 to E18, plasma T3 levels only started to increase
after E18. For T4, plasma levels steadily increased from E14 to C11
while levels in brain in general increased between E14 and E18 and
were lower again at C11 (Fig. 4A–D, Supplementary Table S1).4. Discussion
Thyroid hormones are involved in the timing and regulation
of several neurodevelopmental processes (Williams, 2008).
Therefore, TH action in the developing brain needs to be strictly
controlled. In this study we investigated the expression of genes
that are required for TH uptake and deiodination at the brain
barriers in the chicken. Our results showed expression of TH
transporters and deiodinases as early as E8, indicating that a
mechanism for local control of TH availability is already functional
prior to the maturation of the embryonic thyroid gland. Until then,
all THs are taken up from the yolk and are of maternal origin
(McNabb and Wilson, 1997).
Our results showed that compared to plasma the developing
chicken brain has high T3 levels and a high T3/T4 ratio, a situation
similar to that in the developing rodent and human brain (Calvo
et al., 1990; Kester et al., 2004). This suggests that similar mecha-
nisms are involved in the control of THs in the developing avian
and mammalian brain. However, the distribution of TH trans-
porters and deiodinases at the (adult) mammalian brain barriers
differs from the situation we observed in the developing chicken
embryo. We foundMCT8 to be exclusively expressed at the embry-
onic blood–CSF barrier, whereas in rodents and adult humans
MCT8 mRNA and protein are found both in the choroid plexus
and in the endothelial cells of the brain capillaries (Grijota-
Martinez et al., 2011; Heuer et al., 2005; Roberts et al., 2008b).
Exclusive expression of OATP1C1 in the choroid plexus is similar
to the situation in adult humans, but differs from the situation
described in (foetal) rodents where OATP1C1 mRNA and protein
are also found in the brain microvasculature (Grijota-Martinez
et al., 2011; Muller and Heuer, 2014; Roberts et al., 2008b;
Sugiyama et al., 2003). The high LAT1 mRNA expression at the
chicken blood–brain barrier is in agreement with data from post-
natal/adult rats that showed highly enriched Lat1 mRNA levels in
Fig. 4. T3 and T4 levels in plasma and in different regions of the brain of chicken embryos (E14, E18) and post-hatch chicks (C11). Concentrations are expressed as pmol/ml
plasma or pmol/g brain tissue. Data are presented as means ± SEM (n = 6 for all groups). An overview of the statistics is provided as supplementary data (Supplementary
Table S1).
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Roberts et al., 2008a). Two additional transporters that, based on
data from mammals, could be important in TH uptake across the
blood–brain barrier are MCT10 and LAT2 (Braun et al., 2011). We
were able to visualise faintMCT10mRNA expression in the choroid
plexus, but only at the earliest stage sampled (E8). qPCR analysis
showed an even further decrease of MCT10 expression post-hatch.
Analysis of mouse choroid plexus during development showed
highMct10mRNA expression in the embryonic choroid plexus that
decreased dramatically in the adult (Liddelow et al., 2012). While
LAT2 may be important in TH regulation in mammals (Kinne
et al., 2011; Wirth et al., 2009), we were unable to find a LAT2
homologue in the chicken. Information on the SLC7A8 gene (coding
for LAT2) is not present in any of the currently available bird gen-
omes, nor could we amplify a specific sequence after PCR using
homology based (degenerative) primers. This suggests that the
SLC7A8 sequence is very different or altogether absent from the
avian genomes.
Interspecies/interclass differences also exist in the expression
pattern of the deiodinases. We found high D2 expression in the
blood vessels within the chicken brain (Fig. 2) confirming earlier
data (Gereben et al., 2004), whereas in mammals, D2 is mostly
expressed in astrocytes (Guadano-Ferraz et al., 1997). The pro-
posed mechanism for T3 uptake into the mammalian brain involves
T4 uptake from the blood by the endothelial cells of the blood ves-
sels, transport into the astrocytes where it can be activated to T3 by
D2 and further transported into the neurons containing TH recep-
tors (Heuer and Visser, 2009; Leonard et al., 1994). Our results sug-
gest that in (embryonic) birds a more direct method of T3 uptake in
the brain is possible, with both the TH transporter LAT1 and the
activating enzyme D2 expressed in the endothelial cells of the
brain capillaries, but not in embryonic blood vessel endothelial
cells in the rest of the body. Our results further showed that D3
is the predominant deiodinase in the choroid plexus during
chicken embryonic development. This is in striking contrast with
data from 13 to 20 week old human foetuses, where very high
D2 and very low D3 activity levels were found in the choroidplexus as compared to other brain regions (Kester et al., 2004).
We found both D2 and D3 activity in the choroid plexus before
and after hatching and levels were relatively high compared to
those found earlier in whole brain samples (e.g. Reyns et al.,
2003). Furthermore, while D1 mRNA expression in the embryonic
brain has been described before in both chickens and humans,
D1 activity has never been detected (Chan et al., 2002; Kester
et al., 2004; Van Herck et al., 2012). In this study, however, both
D1 mRNA and specific D1 activity were found in the choroid
plexus. Given the kinetic properties and substrate specificity of
D1 the physiological significance of this finding is unclear. One
possibility is that D1 contributes to the degradation of rT3 pro-
duced locally from T4 by the abundantly expressed D3 enzyme
but at this point this remains speculation.
While the exact timing of the onset of brain barrier functioning
may vary according to the compound studied, it is clear that for
THs, the brain operates within a relative microenvironment from
very early in embryonic development. Levels of T3 are measurable
in the brain as early as E4, before they can be detected in the rest of
the body (Prati et al., 1992; Van Herck et al., 2012). The expression
profile of TH transporters and deiodinases changes over time,
reflecting the changing need for THs (T3) in the brain and/or
changes in the properties of the brain barriers that become increas-
ingly impermeable for intercellular transport. The importance of
the changes at the brain barriers for TH regulation is clear from
the divergence in the pattern of TH changes in the brain as com-
pared to the plasma (Fig. 4). Where T3 levels in the plasma remain
low during embryonic development (E14–E18) and are high post-
hatch (C11), the brain values show peak levels just prior to hatch-
ing and then decline (Fig. 4 and Reyns et al., 2003). Our study
demonstrated that differences in TH levels also exist between the
brain regions, with the forebrain and cerebellum having the high-
est T3 levels. These regional differences in TH levels could be the
result of local differences in the brain barriers, such as increased
capillary density or the close proximity of the choroid plexus.
Another point of interest is the relative importance of the
blood–brain barrier versus the blood–CSF barrier for TH uptake
Fig. 5. Generalised cartoon of the distribution of TH transporters and deiodinases at the brain barriers in the developing chicken brain. In the choroid plexus the barrier is
formed by the tight junctions in the outer epithelial cells, not by the endothelial cells of the blood vessels as is the case in the brain. Arrows indicate possible uptake routes for
THs in the brain. ⁄The shown transport characteristics for MCT8 and LAT1 are based on studies from recombinant human proteins (Friesema et al., 2001; Kinne et al., 2010).
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for THs via TH transporters and deiodinases at the embryonic brain
barriers (see Fig. 5). However, functional characterisation of
chicken TH transporters is lacking except for chicken OATP1C1
which is a T4-specific transporter, similar to the mammalian
OATP1C1 (Nakao et al., 2006). Due to its very large contact surface,
the blood–brain barrier is considered the main exchange route
between the blood and the brain (Abbott et al., 2010) including
for THs in adult rats (Dratman et al., 1991), although the results
for adult rat may not necessarily reflect the situation during
embryonic development, or in other species. We found expression
of several TH transporters in the choroid plexus suggesting that the
blood–CSF barrier also serves an important function in early TH
regulation in the chicken. During embryonic development strap
junctions between the ependymal cells lining the ventricle walls
form a temporary CSF–brain barrier that may restrict the move-
ment of solutes between the CSF and the brain (Ek et al., 2012;
Møllgård et al., 1987). The expression of MCT8 and OATP1C1 in
the ventricle walls may therefore be part of a route for THs to enter
the brain via the CSF.
The high expression and activity of D3 in the choroid plexus
seems counterintuitive to TH uptake. However, detailed imaging
of the choroid plexus showed that gene expression was seldom
homogenously distributed (Figs. 1 and 2). Observation of consecu-
tive tissue sections suggests that regions with high OATP1C1
expression showed low D3 expression, although this needs to be
confirmed by double staining. Moreover, D2 levels in the choroid
plexus increased around hatching, which may have led to a tran-
sient increase in T3 uptake. The prominent and combined LAT1
and D2 expression in the blood vessels suggests that the blood–
brain barrier is the main route for uptake of T3 into the embryonic
chicken brain. The strong decrease in LAT1 expression towards
hatching, however, is contradictory to the surge in T3 in the brain
at this stage (Reyns et al., 2003), and indicates that other TH trans-
porters or uptake mechanisms have to be involved. In this regard
the combined expression of MCT8 and D2 in the tanycytes liningthe 3rd ventricle is interesting since it may indeed provide an addi-
tional route for access of T3 to the developing hypothalamic
neurons.
Synthesis of the TH distributor protein TTR by the choroid
plexus has been implicated in the transport of T4 (but not T3) from
the blood into the CSF for the past few decades (Chanoine et al.,
1992; Monnot et al., 2012; Shi and Zheng, 2007). Furthermore,
the profile of TTR synthesis in the choroid plexus exactly reflects
the peak of TH entry into the brain prior to the maximal brain
growth for both altricial and precocial species (see Richardson,
2005). Our own analysis of TTR mRNA expression in the choroid
plexus showed a dramatic increase towards hatching (Fig. 3C)
corresponding to peak TH levels in the brain, consolidating this
observation. Controversy on the role of TTR in tissue uptake of
THs arose when TTR null mice appeared to have no overt pheno-
type (Episkopou et al., 1993; Palha et al., 1997, 2002) and several
high affinity TH transporters started to be discovered (Friesema
et al., 2001, 2003). However, TTR null mice have significantly
reduced levels of T4 in the brain (Palha et al., 1997; Richardson
et al., 2007) and recently have been shown to have a delayed mat-
uration of the central nervous system (Monk et al., 2013). Thus,
TTR synthesised by the choroid plexus must have a role in either
movement of THs from the blood into the CSF, or in the dis-
tribution of THs within the CSF, or both. Therefore, several interact-
ing mechanisms at the brain barriers may ensure that the brain
receives the correct amount of THs at each stage of development.
It is becoming increasingly clear that while THs have the same
action mechanism and control similar neurodevelopmental pro-
cesses in different vertebrates (Bernal, 2005; Darras et al., 2009;
de Vrieze et al., 2014; Denver, 1998), the regulation of TH availabil-
ity in the (developing) brain shows remarkable interspecies/
interclass differences. Even amongst mammals, species-specific
differences in TH transporter expression at the blood–brain barrier
are thought to underlie the strikingly different phenotypes in
MCT8-deficient humans and mice. Mct8 null mice show only a
mildly deficient neurological phenotype compared to the severe
38 S.L.J. Van Herck et al. / General and Comparative Endocrinology 214 (2015) 30–39Allan–Herndon–Dudley syndrome in MCT8-deficient humans
(Dumitrescu et al., 2006; Trajkovic et al., 2007). One important
difference may be the differential expression of OATP1C1 at the
blood–brain barrier since mice with a combined knockout of
Mct8/Oatp1c1 show a pronounced decrease in TH uptake in the
brain and suffer from a more severe phenotype (Mayerl et al.,
2014; Roberts et al., 2008b).
We can conclude that the brain barriers play an important role
in the regulation of TH levels during embryonic development. Even
during early embryonic development, the brain develops in a
microenvironment with a high T3/T4 ratio and is able to alter TH
levels differently from the changes occurring in the general
circulation. We found specific expression of TH transporters and
deiodinases at both the blood–CSF barrier (choroid plexus) and
the blood–brain barrier (microvessels). LAT1 and D2 mRNA are
abundantly expressed in the blood vessels of the developing brain
suggesting that the blood–brain barrier forms the main route for T3
uptake. Expression of a wide variety of TH transporters and deiodi-
nases in the choroid plexus shows that the blood–CSF barrier is
also an important site for the regulation of TH availability in the
embryonic brain, although its precise functional significance
remains unclear.
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